December 19, 2019
Published by Meranda Parascandola at December 19, 2019
A scientific review of the pertinent development data provides the necessary information to assure that informed decisions are made regarding the potential in-licensing of a development compound. By highlighting perceived risks and resource implications, the examination provides assurance that a given compound meets the requisite technical and quality elements.In advance of Biotech Showcase and the JP Morgan Healthcare Conferences next month, we are providing our complementary Drug Product Due Diligence Checklist. Send us a message if you would like a copy.
September 20, 2019
Published by Meranda Parascandola at September 20, 2019
Drug Substance Development Expert, Dr. James Mencel, will be presenting “Expedited Filings and their CMC Implications: Considerations toward Better Planning”, sponsored by AMRI, a global contract research and manufacturing organization. Conference sessions will occur at AMRI’s Corporate Headquarters.
August 15, 2019
Published by Meranda Parascandola at August 15, 2019
DSI to Showcase Progressive Drug Development Strategies and Products at the 2019 Biotech Week Boston
DSI will be attending Biotech Week Boston 2019, find us at BioPharm America on September 09-12th. Biotech Week Boston is dedicated to accelerating the business of biotechnology through new ideas, science, technology and partnerships to make a positive impact on patient health.
May 10, 2019
Published by Meranda Parascandola at May 10, 2019
I have never been so simultaneously energized and exhausted than during BIO Week. From the moment you arrive in the city, you’ll experience morning to evening activity. From keynote speeches with luminaries, to panels and partnering meetings with pharma CEOs, to a number of parties ranging from circus performers to whiskey tastings, to yes… Cheesesteak options!
April 10, 2019
Published by Meranda Parascandola at April 10, 2019
DSI, the leading Chemistry, Manufacturing and Controls consulting firm, today announced its participation in CPhI North America, the only Pharmaceutical Industry Event for the North American Supply Chain. This three-day event will be held on April 30-May 2, at the Lakeside Center at McCormick Place, Chicago, Illinois.
March 8, 2019
Published by Meranda Parascandola at March 8, 2019
DCAT is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. Held annually in March, DCAT Week ensures that members have a forum for high-level strategic meetings with key decision makers, timely educational programs, and important networking opportunities.